Evoke Wealth’s Lam Research LRCX Stock Holding History

Evoke Wealth’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.38M	Hold	39,200	–	–	0.15%	64
2025 Q4	$6.71M	Buy	+39,200	New	+$6.1M	0.13%	72

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Evoke Wealth's LRCX Position: Q1 2026 in Review

Evoke Wealth reduced its Lam Research (LRCX) stake by 8.3% in Q1 2026, selling an estimated $936K and leaving 45,948 shares worth $9.83M. The position accounts for 0.18% of the portfolio, ranked #56.

Evoke Wealth first reported a position in LRCX in Q3 2019 and has held it in 19 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Evoke Wealth held 45,948 shares of Lam Research worth $9.83M as of Q1 2026.
Evoke Wealth sold 4,184 Lam Research shares in Q1 2026, an estimated $936K.
Lam Research made up 0.18% of Evoke Wealth's portfolio in Q1 2026, its #56 holding.
Evoke Wealth first reported a position in Lam Research in Q3 2019 and has held it in 19 quarters since.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.